From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

From vaccine development to cancer and cell or gene therapies, LipidLaunch™ research-ready lipid nanoparticles and reagent ...

CD Bioparticles launches an advanced animal mRNA vaccine platform to accelerate the development of vaccines for veterinary applications.

The Global Nanomedicine Market is expected to witness a growth rate of 10-12% in the next five years. Ongoing research and ...

A joint Singaporean-Chinese research team has developed an Evans Blue-modified lipid nanoparticle platform that directs mRNA vaccines to lymph nodes, reduces liver exposure and enhances ...